Search
×
FR

Placeholder headline

This is just a placeholder headline

API TR 5C3: Calculating Performance Properties of Pipe Used as Casing or Tubing

$

422

BUY NOW

Placeholder headline

This is just a placeholder headline

API STD 671: Special Purpose Couplings for Petroleum, Chemical and Gas Industry Services

$

502

BUY NOW

Placeholder headline

This is just a placeholder headline

Technical Report API TBD-10: Chapter 10 Surface and Interfacial Tension

$

176

BUY NOW

Placeholder headline

This is just a placeholder headline

API STD 671: Special Purpose Couplings for Petroleum, Chemical and Gas Industry Services: Errata 2

$

0

BUY NOW

Placeholder headline

This is just a placeholder headline

MSS SP-44-2026: Steel Pipeline Flanges

$

450

BUY NOW

Placeholder headline

This is just a placeholder headline

API RP 576: Inspection of Pressure-relieving Devices

$

460

BUY NOW

Placeholder headline

This is just a placeholder headline

API RP 591: Process Valve Qualification Procedure

$

226

BUY NOW

Placeholder headline

This is just a placeholder headline

API RP 576: Inspection of Pressure-relieving Devices: Addendum 1

$

0

BUY NOW

ISO 14155:2020

ISO 14155:2020 Clinical investigation of medical devices for human subjects – Good clinical practice

CDN $417.00

SKU: 9c7cae68e1a2 Categories: ,

Description

This document addresses good clinical practice for the design, conduct, recording and reporting of clinical investigations carried out in human subjects to assess the clinical performance or effectiveness and safety of medical devices.

For post-market clinical investigations, the principles set forth in this document are intended to be followed as far as relevant, considering the nature of the clinical investigation (see Annex I).

This document specifies general requirements intended to

– protect the rights, safety and well-being of human subjects,

– ensure the scientific conduct of the clinical investigation and the credibility of the clinical investigation results,

– define the responsibilities of the sponsor and principal investigator, and

– assist sponsors, investigators, ethics committees, regulatory authorities and other bodies involved in the conformity assessment of medical devices.

NOTE 1 Users of this document need to consider whether other standards and/or national requirements also apply to the investigational device(s) under consideration or the clinical investigation. If differences in requirements exist, the most stringent apply.

NOTE 2 For Software as a Medical Device (SaMD) demonstration of the analytical validity (the SaMD’s output is accurate for a given input), and where appropriate, the scientific validity (the SaMD’s output is associated to the intended clinical condition/physiological state), and clinical performance (the SaMD’s output yields a clinically meaningful association to the target use) of the SaMD, the requirements of this document apply as far as relevant (see Reference [4]). Justifications for exemptions from this document can consider the uniqueness of indirect contact between subjects and the SaMD.

This document does not apply to in vitro diagnostic medical devices. However, there can be situations, dependent on the device and national or regional requirements, where users of this document might consider whether specific sections and/or requirements of this document could be applicable.

Edition

3

Published Date

2020-07-28

Status

PUBLISHED

Pages

83

Language Detail Icon

English

Format Secure Icon

Secure PDF

Abstract

This document addresses good clinical practice for the design, conduct, recording and reporting of clinical investigations carried out in human subjects to assess the clinical performance or effectiveness and safety of medical devices.

For post-market clinical investigations, the principles set forth in this document are intended to be followed as far as relevant, considering the nature of the clinical investigation (see Annex I).

This document specifies general requirements intended to

- protect the rights, safety and well-being of human subjects,

- ensure the scientific conduct of the clinical investigation and the credibility of the clinical investigation results,

- define the responsibilities of the sponsor and principal investigator, and

- assist sponsors, investigators, ethics committees, regulatory authorities and other bodies involved in the conformity assessment of medical devices.

NOTE 1 Users of this document need to consider whether other standards and/or national requirements also apply to the investigational device(s) under consideration or the clinical investigation. If differences in requirements exist, the most stringent apply.

NOTE 2 For Software as a Medical Device (SaMD) demonstration of the analytical validity (the SaMD's output is accurate for a given input), and where appropriate, the scientific validity (the SaMD's output is associated to the intended clinical condition/physiological state), and clinical performance (the SaMD's output yields a clinically meaningful association to the target use) of the SaMD, the requirements of this document apply as far as relevant (see Reference [4]). Justifications for exemptions from this document can consider the uniqueness of indirect contact between subjects and the SaMD.

This document does not apply to in vitro diagnostic medical devices. However, there can be situations, dependent on the device and national or regional requirements, where users of this document might consider whether specific sections and/or requirements of this document could be applicable.

Previous Editions

Can’t find what you are looking for?

Please contact us at: